Združene države Amerike - angleščina - NLM (National Library of Medicine)

international laboratories, llc - atorvastatin calcium propylene glycol solvate (unii: yrz789owmi) (atorvastatin - unii:a0jwa85v8f) - atorvastatin 40 mg - therapy with lipid-altering agents should be only one component of multiple risk factor intervention in individuals at significantly increased risk for atherosclerotic vascular disease due to hypercholesterolemia. drug therapy is recommended as an adjunct to diet when the response to a diet restricted in saturated fat and cholesterol and other nonpharmacologic measures alone has been inadequate. in patients with chd or multiple risk factors for chd, atorvastatin calcium tablets can be started simultaneously with diet. in adult patients without clinically evident coronary heart disease, but with multiple risk factors for coronary heart disease such as age, smoking, hypertension, low hdl-c, or a family history of early coronary heart disease, atorvastatin calcium tablets are indicated to: - reduce the risk of myocardial infarction - reduce the risk of stroke - reduce the risk for revascularization procedures and angina  in patients with type 2 diabetes, and without clinically evident coronary heart disease, but

Kanada - angleščina - Health Canada

apotex inc - amlodipine (amlodipine besylate); atorvastatin (atorvastatin calcium propylene glycol solvate) - tablet - 5mg; 10mg - amlodipine (amlodipine besylate) 5mg; atorvastatin (atorvastatin calcium propylene glycol solvate) 10mg - hmg-coa reductase inhibitors

Kanada - angleščina - Health Canada

apotex inc - amlodipine (amlodipine besylate); atorvastatin (atorvastatin calcium propylene glycol solvate) - tablet - 5mg; 20mg - amlodipine (amlodipine besylate) 5mg; atorvastatin (atorvastatin calcium propylene glycol solvate) 20mg - hmg-coa reductase inhibitors

Kanada - angleščina - Health Canada

apotex inc - amlodipine (amlodipine besylate); atorvastatin (atorvastatin calcium propylene glycol solvate) - tablet - 5mg; 40mg - amlodipine (amlodipine besylate) 5mg; atorvastatin (atorvastatin calcium propylene glycol solvate) 40mg - hmg-coa reductase inhibitors

Kanada - angleščina - Health Canada

apotex inc - amlodipine (amlodipine besylate); atorvastatin (atorvastatin calcium propylene glycol solvate) - tablet - 5mg; 80mg - amlodipine (amlodipine besylate) 5mg; atorvastatin (atorvastatin calcium propylene glycol solvate) 80mg - hmg-coa reductase inhibitors

Kanada - angleščina - Health Canada

apotex inc - amlodipine (amlodipine besylate); atorvastatin (atorvastatin calcium propylene glycol solvate) - tablet - 10mg; 10mg - amlodipine (amlodipine besylate) 10mg; atorvastatin (atorvastatin calcium propylene glycol solvate) 10mg - hmg-coa reductase inhibitors

Kanada - angleščina - Health Canada

apotex inc - amlodipine (amlodipine besylate); atorvastatin (atorvastatin calcium propylene glycol solvate) - tablet - 10mg; 20mg - amlodipine (amlodipine besylate) 10mg; atorvastatin (atorvastatin calcium propylene glycol solvate) 20mg - hmg-coa reductase inhibitors

Kanada - angleščina - Health Canada

apotex inc - amlodipine (amlodipine besylate); atorvastatin (atorvastatin calcium propylene glycol solvate) - tablet - 10mg; 40mg - amlodipine (amlodipine besylate) 10mg; atorvastatin (atorvastatin calcium propylene glycol solvate) 40mg - hmg-coa reductase inhibitors

Kanada - angleščina - Health Canada

apotex inc - amlodipine (amlodipine besylate); atorvastatin (atorvastatin calcium propylene glycol solvate) - tablet - 10mg; 80mg - amlodipine (amlodipine besylate) 10mg; atorvastatin (atorvastatin calcium propylene glycol solvate) 80mg - hmg-coa reductase inhibitors

Avstralija - angleščina - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - amlodipine besilate, quantity: 10 mg; valsartan, quantity: 160.001 mg - tablet - excipient ingredients: magnesium stearate; powdered cellulose; purified talc; hyprolose; iron oxide yellow; calcium hydrogen phosphate; iron oxide red; hypromellose; macrogol 8000; silicon dioxide; titanium dioxide; purified water; aluminium magnesium silicate; croscarmellose sodium - the treatment of hypertension. treatment should not be initiated with this fixed dose combination.